Cancer Advances
Subscribe:
Featured Episode
The MiDe Study’s Approach to Predict, Prevent and Detect Ovarian Cancer
Kevin Elias, MD, the Lilli and Seth Harris Endowed Chair for Ovarian Cancer at Cleveland Clinic, joins the Cancer Advances podcast to discuss the challenges of trying to detect ovarian cancer early and the need for better predictive tools. Listen as Dr. Elias talks about the MiDe Study, which aims to identify high-risk women through microRNA-based blood tests, potentially transforming ovarian cancer screening and prevention.
Play NowAll Cancer Advances Episodes
March 13, 2025
Insights into Advanced Surgical Techniques for Neuroblastoma
Gloria Gonzalez, MD, Pediatric Surgeon and Director of Pediatric Surgical Oncology, joins the Cancer Advances podcast to provide her insights on advanced surgical techniques for neuroblastoma. Listen as Dr. Gonzalez explains the complexities of neuroblastoma, the use of 3D printing in preoperative planning and 3D image-guided surgery, and the emerging role of fluorescent-guided surgery.
Play NowMarch 6, 2025
Integrative Oncology Program
The Cancer Advances podcast is joined by the Chair of the Palliative and Supportive Care Department, Laura Shoemaker, DO, and Integrative Medicine Specialist, Naoki Umeda, MD, to talk about Cleveland Clinic's Integrative Oncology Program. Listen as they share how combining evidence-based complementary therapies, such as acupuncture and lifestyle medicine, with conventional cancer treatment can help alleviate symptoms, enhance patients' quality of life, and improve outcomes.
Play NowFebruary 27, 2025
Bispecific Antibodies and Immunotherapy for Aggressive Lymphomas
Paolo Caimi, MD, Associate BMT Director for Cell Therapy at Cleveland Clinic Cancer Institute, joins the Cancer Advances podcast to discuss the latest advancements in immunotherapy for aggressive lymphomas. Listen as Dr. Caimi talks about the potential of bispecific antibody combinations, including early-phase findings on glofitamab plus ICE chemotherapy for relapsed and refractory diffuse large B-cell lymphoma.
Play NowFebruary 20, 2025
The Potential of CAR T-Cell Therapy for Chronic Lymphocytic Leukemia (CLL)
Vice Chair of the Center for Immunotherapy and Precision Immuno-Oncology, J. Joseph Melenhorst, PhD, joins the Cancer Advances Podcast to discuss the potential of CAR T-cell therapy for chronic lymphocytic leukemia (CLL). Listen as Dr. Melenhorst explains how advancements in cell therapy are overcoming challenges like T cell exhaustion, improving response rates, and how novel approaches could improve treatment outcomes.
Play Now
